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Abstract
Mammary tumors of female dogs have greatly increased in recent years, thus demanding rapid diagnosis and
effective treatment in order to determine the animal survival. There is considerable scientific interest in the possible
role of environmental contaminants in the etiology of mammary tumors, specifically in relation to synthetic chemi-
cal substances released into the environment to which living beings are either directly or indirectly exposed. In this
study, the presence of pyrethroid insecticide was observed in adjacent adipose tissue of canine mammary tumor.
High Precision Liquid Chromatography - HPLC was adapted to detect and identify environmental contaminants in
adipose tissue adjacent to malignant mammary tumor in nine female dogs, without predilection for breed or age.
After surgery, masses were carefully examined for malignant neoplastic lesions. Five grams of adipose tissue adja-
cent to the tumor were collected to detect of environmental contaminants. The identified pyrethroids were alle-
thrin, cyhalothrin, cypermethrin, deltamethrin and tetramethrin, with a contamination level of 33.3%.
Histopathology demonstrated six female dogs (66.7%) as having complex carcinoma and three (33.3%) with simple
carcinoma. From these tumors, seven (77.8%) presented aggressiveness degree III and two (22.2%) degree I. Five
tumors were positive for estrogen receptors in immunohistochemical analysis. The contamination level was
observed in more aggressive tumors. This was the first report in which the level of environmental contaminants
could be detected in adipose tissue of female dogs with malignant mammary tumor, by HPLC. Results suggest the
possible involvement of pyrethroid in the canine mammary tumor carcinogenesis. Hence, the dog may be used as
a sentinel animal for human breast cancer, since human beings share the same environment and basically have
the same eating habits.
Introduction
Currently, mammary tumors represent 50% of all neo-
plasms that afflict female dogs [1,2], and from these
tumors 41 to 53% are of malignant character [3-5]. Epi-
demiological and clinical characteristics as well as biolo-
gical behavior of such tumors in female dogs are similar
to breast carcinomas in women, for this reason female
dogs present an excellent comparative model to under-
stand various aspects of carcinogenesis in both species
[6]. It is believed that mammary neoplasias may occur
as a result of complex interactions of distinct factors;
however the exact cause is still under research. Through
this dynamic process, the mammary tumor can be influ-
enced by internal host factors such as genetics and
external factors, including environmental contamination,
that can enable or reduce the individual response [7-9].
The pyrethroids are among environmental contaminants
the ones whose use has exponentially grown in recent
years [10]. They are used to control pests in agriculture,
ranching and domestic animals. The overspread use of
this contaminant is associated with its efficiency in pest
control and its relatively short half-life [11-13]. In
humans and other animals, pyrethroids are readily
absorbed cutaneously and also in the digestive and
respiratory tracts. Once absorbed they are distributed to
various tissues, but they are concentrated especially in
the adipose tissue. International Agency for Research
Cancer (IARC) includes agrotoxins, especially deltame-
thrin and cypermethrin in group 3 of risk level, that is,
non-conclusive carcinogenic for humans, while the
World Health Organization (WHO) classifies deltame-
thrin as a moderately dangerous insecticide [14,15].
Considering that this research line is still not used in
regular basis for the veterinary medicine, the present
study aimed to detect and identify levels of pyrethroid
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insecticides in adipose tissue adjacent to malignant
mammary tumor in female dogs by the HPLC method
and correlate these contaminants with the aggressive-
ness degree of the neoplasias.
Material and Methods
Nine female dogs with mammary gland swelling (Fig. 1)
were attended at the UNESP Veterinary Hospital in
Botucatu, São Paulo - Brazil, and underwent mastec-
tomy to excise the tumor (Fig. 2). Five grams of adipose
tissue adjacent to the mammary tumor were analyzed by
High Precision Liquid Chromatography - HPLC, follow-
ing the Bissacot and Vassilieff method [16] (1997). Frag-
ments of mammary tumor were fixed in 10% buffered
formalin for 24 h, and then they were dehydrated in
alcohol, diaphanized in xylene and put into paraffin.
They were then cut into 3 μm-width fragments and
stained with Hematoxylin-Eosin (HE). For the analysis
of tumors it was used the Veterinary [17] and Human
[18] classification. Immunohistochemical analysis fol-
lowed the protocols from the Immunohistochemistry
Laboratory from the Department of Clinical Veterinary
Medicine of the School of Veterinary Medicine and Ani-
mal Science - UNESP - Botucatu. Antigen retrieval was
carried out by microwave treatment in a 10 mM citrate
buffer, pH 6.0. Tissue sections were incubated with pri-
mary monoclonal antibodies against ER (Novocastra -
UK), clone LH2, in 1:40 dilution, incubated for 120 min
and developed with polymer Novolink (Novocastra, UK).
Tumors were considered positive when they presented
more than 10% of nuclear marks from marked neoplasic
cells. Graduations were set according to the intensity of
positive marking as follows: (+) low intensity (++) mild
intensity and (+++) high intensity described in previous
studies [19].
Results
According to the Veterinary classification, from the nine
examined tumors, three (33.3%) were classified as simple
carcinoma (Fig. 3), and six (66.7%) as complex carci-
noma (Fig. 4). But when it comes to the Human Medi-
cine classification these nine cases were divided into:
three (33.3%) simple carcinoma, being one tubulo-papil-
liferous, one ductal, one ductal infiltrative, and six
(66.7%) metaplasic carcinomas. As for the histological
malignity two tumors were degree I (22,2%) and seven
tumors were degree III (77,8%). Receptors marking were
positive for 5 animals, regardless of their mark intensity.
From 9 analyzed female dogs, pyrethroids were detected
in three animals distributed in the following manner:
one (11.1%) female dog with 0.55 mg/g of deltamethrin
and 0.32 mg/g of cyhalothrin; one (11.1%) female dog
Figure 1 great increase in right cranial mammary gland.
Figure 2 tumor after unilateral mastectomy.
Figure 3 Simple Carcinoma. Neoplasia composed by proliferated
epithelium cells, generating a hard standard with the loss of the
glandular architecture.
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with 0.02 mg/g of deltamethrin and 0.05 mg/g of alle-
thrin and one (11.1%) female dog with 0.03 mg/g of
cypermethrin. Results are shown in table 1 and in the
HPLC graphics (see Additional file 1).
Discussion
It is very little the number of studies connecting steroid
hormone receptors and mammary tumors in female
dogs. However, some human and canine carcinogenic
hormone aspects seem to be similar. Toxicological and
Epidemiological studies have shown that steroid hor-
mones and synthetic derived trigger the development of
mammary gland, suggesting that they may play an
important role in the canine mammary tumor patho-
genesis [20].
It is said that in the hormonal carcinogenesis, unlike
the one induced by virus or chemical agents, the cell
proliferation does not need a specific triggering agent.
Hormones induce the cell proliferation together with
genetic mutations that will give rise to neoplasic cells
[21]. However, Carreño et al. (1999) [22], shows that the
hormone role in the carcinogenesis is restricted to the
proliferation of cells that have already been changed by
other carcinogens. Specific genes involved in the devel-
opment of hormone-dependent neoplasias are still
unknown. Nevertheless, it is believed that oncogenes,
genes that are tumor suppressors and the genes of DNA
repairment are involved in the hormonal carcinogenesis,
especially in the one induced by sexual steroids [23].
Having said that, this study has shown that the detected
contaminants were present in more aggressive tumors
(degree III and +++ for estrogen receptors- Fig.5 and 6).
Even though the literature showing that being positive
for estrogen receptors may result in good prognostic for
women [24], the results from this preliminary study sug-
gest that the presence of pyrehroids in the peritumoral
fat may have triggered the local estrogenic effect and
thus triggered higher proliferation of tumor cells.
Scheme below (Fig. 7) shows the carcinogenesis of
mammary tumor and the role of pyrethroids in the pro-
liferation of tumors.
Epidemiological studies and tests on rodents have
demonstrated the influence of environmental contami-
nants on neoplasia development, including breast cancer
[10,25,26]. Garey et al, (1998) [27] emphasized that pyr-
ethroids can induce a breakdown in the homeostasis of
hormones such as estrogens and indirectly influence cell
Figure 4 Complex carcinoma. Neoplasia composed by more than
one cell type. Proliferated epithelial cells, with loss of gland
architecture and presenting pleomorphism. Elongated mioeptithelial
cells, presenting cartilagenous metaplasia and condroid matrix
production. HE, 200X.
Figure 5 Estrogen receptors’ Immunohistochemical picture.
Observe the nuclear pattern marking. Simple carcinoma, grade III, +
++ for ER. 200X.
Figure 6 Estrogen receptors’ Immunohistochemical picture.
Complex carcinoma, grade III, +++ for ER. 400X.
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proliferation or apoptosis, either increasing or diminish-
ing them in mammary epithelial cells, thereby triggering
the neoplastic process. Results obtained in the present
study detected the presence of 33.3% of pyrethroid
pesticides in adipose tissue of female dogs with mam-
mary carcinoma.
In order to improve results, and collection of data, our
group is still researching such environmental
Table 1 Veterinary and Human histopathological classification of Malignant mammary tumor in female dogs showing
their malignity, positive immunemarking for estrogen receptors, and pyrethroid identification with their respective
concentration levels in the analyzed samples
Classification - Carcinoma Degree Estrogen Receptor HPLC
Veterinary Human μg/g Pyrethroid
Simple Tubulo-papilliferous III +++ 0.55 0.32 Deltamethrin Cyhalothrin
Complex Metaplasic I 0 ————————————
Complex Metaplasic III +++ 0.05 0.02 Allethrin Deltamethrin
Complex Metaplasic III 0 ————————————
Simple Ductal I ++ ————————————
Simple Ductal infiltrative III + ————————————
Complex Metaplasic III +++ 0.03 Cypermethrin
Complex Metaplasic III 0 ————————————
Complex Metaplasic III 0 —————————————
Figure 7 Mammary carcinogenesis in the presence of pyrethroids.
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contamination, increasing the number of samples as well
as including samples from control animals.
Additional material
Additional file 1: Standard for HPLC of pyrethroids and adipose tissue
with pyrethroid contamination. Graphics presenting the standard data for
HPLC of pyrethroids and adipose tissue with pyrethroid contamination.
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